Looking to publish in Helicobacter? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowHelicobacter is a broad scope journal covering the entire field of helicobacter research, increasing communication among fields including gastroenterology, microbiology, vaccine development, and laboratory animal science. It covers new discoveries in molecular biology and clinical trials of new treatment for patient care.
Looking to publish in Helicobacter? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Helicobacter accepts the following article types. Click on an article type to view submission instructions.
Original Articles
Reviews
Brief Communications
Letters To The Editor
Case Reports
Recent Publications
Gastric Cancer Incidence After Helicobacter pylori Eradication and Lifestyle‐Related Risk Factors: A Population‐Based Cohort Study
Junya Arai, Ryota Niikura, Yoku Hayakawa, Hiroaki Fujiwara, Mitsuhiro Fujishiro, Masato Kasuga
High Eradication Rate of a Potassium‐Competitive Acid Blocker‐Based Minocycline, Furazolidone, and Bismuth Regimen for Refractory Helicobacter pylori Infection: A Real‐World Study
Ji‐Yan Li, Ying‐Ying Han, Dong‐Yan Li, Jing‐Mei Liu, Zhen‐Zhen Zhou, Ya‐Ni Zhou, Lin Tuo, Xiao‐Jiao Yao, Mei Liu, Ge Wang, Pei‐Yuan Li
High‐Dose Dual Therapy Versus Bismuth‐Containing Quadruple Therapy as Rescue Treatment for Helicobacter pylori Infection: Systematic Review and Meta‐Analysis
Liang Zhang, Jian Liu, Da Li, Yali Wang
A Bidirectional Association Between Helicobacter pylori Infection and Hyperlipidemia: Clinical Evidence and Mechanistic Insights
Yan'an Zhou, Yuchen Zhu, Shuai Li, Zekun He, Yao Zhang, Zonglei Wang, Cong He, Hongtao Zhu, Nianshuang Li, Junming Li, Junyun Feng, Xiao Fei, Xingxing He, Huan Wang, Da Gan, Xia Huang, Nonghua Lv, Yuhui Wang, Wenhua He, Xidong Wu, Yin Zhu, Jianping Liu
Correction to “Tegoprazan‐Based Triple Therapy for Helicobacter pylori Eradication: A Phase III Multicenter Randomized Clinical Trial”
-
Frequently asked questions
How long does it take to publish?
Median 3 days from submission to first decision, 75 days from submission to acceptance, and 13 days from acceptance to publication.
Reformat to Helicobacter using Livewrite PremiumWhat are the publication costs?
Open access APC: $4,360 USD / £2,860 GBP / €3,650 EUR.
Reformat to Helicobacter using Livewrite Premium